Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: Benefit of deep inspiration breath-hold

Acta Oncologica

Volumn 54, Issue 1, 2015, Pages 60-66

  Petersen, Peter M ^a   Aznar, Marianne C ^a,b   Berthelsen, Anne K ^a   Loft, Annika ^a   Schut, Deborah A ^a   Maraldo, Maja ^a   Josipovic, Mirjana ^a   Klausen, Thomas L ^a   Andersen, Flemming L ^a   Specht, Lena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; VINBLASTINE; ANTINEOPLASTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AORTA VALVE; ARTICLE; BREAST; BREATHING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DEEP INSPIRATION BREATH HOLD; FEMALE; FREE BREATHING; HEART; HEART VALVE; HODGKIN DISEASE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INVOLVED NODE RADIOTHERAPY; LUNG; MALE; MITRAL VALVE; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY PLANNING SYSTEM; TRICUSPID VALVE; BREATH HOLDING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; INHALATION; MIDDLE AGED; MULTIMODAL IMAGING; ORGANS AT RISK; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; SCINTISCANNING; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; BREATH HOLDING; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HODGKIN DISEASE; HUMANS; INHALATION; LUNG; MALE; MIDDLE AGED; MULTIMODAL IMAGING; ORGANS AT RISK; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY, IMAGE-GUIDED; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84919687481     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.932435     Document Type: Article

References (25)

1. Eich H. T, Diehl V, Gorgen H, Pabst T, Markova J, Debus J, et al. Intensifi ed chemotherapy and dose-reduced involvedfi eld radiotherapy in patients with early unfavorable Hodgkin s lymphoma: Final analysis of the German hodgkin Study Group HD11 trial. J Clin Oncol 2010;28:4199-206
2. Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkins lymphoma. N Engl J Med 2010;363:640-52
3. Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, et al. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkins lymphoma: Final analysis of the HD12 trial of the German hodgkin Study Group. J Clin Oncol 2011;29:4234-42
4. Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkins disease treated at age 50 or younger. J Clin Oncol 2002;20:2101-8
5. Aleman B. M, van Den Belt-Dusebout AW, Klokman W. J, vant Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for hodgkins disease. J Clin Oncol 2003;21:3431-9
6. Dores G. M, Metayer C, Curtis RE, Lynch C. F, Clarke E. A, Glimelius B, et al. Second malignant neoplasms among longterm survivors of hodgkins disease: A population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94
7. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of hodgkins disease. JAMA 1993;270:1949-55
8. Travis L. B, Gospodarowicz M, Curtis R. E, Clarke E. A, Andersson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for hodgkins disease. J Natl Cancer Inst 2002;94:182-92
9. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with hodgkin disease. JAMA 2003;290:465-75
10. Hull M. C, Morris C. G, Pepine C. J, Mendenhall N. P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 2003;290:2831-7
11. Girinsky T, van Der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol 2006;79:270-7
12. Girinsky T, Specht L, Ghalibafi an M, Edeline V, Bonniaud G, van Der Maazen R, et al. The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 2008;88:202-10
13. Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, et al. Modern radiation therapy for hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys Epub 2013 Jun 18. pii: S0360-3016(13)00534-8. doi: 10.1016/j.ijrobp.2013.05.005
14. Paumier A, Ghalibafi an M, Gilmore J, Beaudre A, Blanchard P, el Nemr M, et al. Dosimetric benefi ts of intensity-modulated radiotherapy combined with the deepinspiration breath-hold technique in patients with mediastinal Hodgkins lymphoma. Int J Radiat Oncol Biol Phys 2012;82:1522-7
15. Paumier A, Ghalibafi an M, Beaudre A, Ferreira I, Pichenot C, Messai T, et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2011;80:199-205
16. Korreman SS, Pedersen AN, Nottrup TJ, Specht L, Nystrom H. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005;76:311-8
17. Damkjaer SM, Aznar MC, Pedersen A. N, Vogelius IR, Bangsgaard JP, Josipovic M. Reduced lung dose and improved inspiration level reproducibility in visually guided DIBH compared to audio coached EIG radiotherapy for breast cancer patients. Acta Oncol 2013;52:1458-63
18. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011;79:10-8
19. de Boer HC, Heijmen BJ. eNAL: An extension of the NAL setup correction protocol for effective use of weekly follow-up measurements. Int J Radiat Oncol Biol Phys 2007;67:1586-95
20. Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af Rosensch ö ld P, Petersen PM, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 2013;24:2113-8
21. Gilbert ES, Stovall M, Gospodarowicz M, van Leeuwen FE, Andersson M, Glimelius B, et al. Lung cancer after treatment for hodgkins disease: Focus on radiation effects. Radiat Res 2003;159:161-73
22. Hodgson D. C, Gilbert E. S, Dores G. M, Schonfeld SJ, Lynch CF, Storm H, et al. Long-term solid cancer risk among 5-year survivors of hodgkins lymphoma. J Clin Oncol 2007;25:1489-97
23. Swerdlow AJ, Schoemaker MJ, Allerton R, Horwich A, Barber JA, Cunningham D, et al. Lung cancer after hodgkins disease: A nested case-control study of the relation to treatment. J Clin Oncol 2001;19:1610-8
24. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, vant Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following hodgkins disease. J Natl Cancer Inst 2003;95:971-80
25. Darby SC, Ewertz M, McGale P, Bennet A. M, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-98